Letter from the CEO
This issue of The Teal Journal is going to press just a few days after the 2011 meeting of the American Society of Clinical Oncology concluded. The meeting included many briefings, presentations and posters relevant to the ovarian cancer community. Progress in the development of targeted therapies was particularly attention-grabbing. This month, The Teal Journal includes summaries of several of the meeting’s presentations that were most noteworthy for anyone touched by ovarian... Read More
Ask the Expert
Moshe Shike, MD Director of Clinical Nutrition, Memorial Sloan-Kettering Cancer Center Is there a connection between food and cancer? Google the two words together and 12,800,000 links appear. Individuals are not the only ones looking for complementary additions to traditional medical therapies; researchers and doctors at the leading universities/cancer centers across the globe are also exploring this topic. Even chefs have been brought into the conversation. For example, Dan... Read More
Report from Capitol Hill: The Fight for Ovarian Cancer Research Funding
The Fiscal Year 2011 Congressional appropriations cycle was a nerve-wracking time for the ovarian cancer community. Because the federal government is the largest funder of ovarian cancer research and awareness programs, the Ovarian Cancer National Alliance continuously educates Congress about the necessity of increasing funding for research and education programs. Two key ovarian cancer programs are the Department of Defense’s (DoD) Ovarian Cancer Research Program and the Centers... Read More
2011 Annual Conference: Turning Promise Into Action
The Ovarian Cancer National Alliance Annual Conference is one of the most important ways the Alliance bridges the gap between survivors and science. The conference brings the latest scientific discoveries and research to the ovarian cancer community, and brings our community to Capitol Hill to advocate for federal funding that supports further research in the field. Patricia Goldman, a board member of the Alliance, has seen that dynamic play out at past conferences: “Since they... Read More
Cancer Vaccines at the Vanguard of Treatment
Cancer is fundamentally a disease of genes gone awry and escaping the immune system. Cancer cells, rapidly dividing, can form lumps, spread and halt functioning of important biological systems. Many treatments in use today target rapidly dividing cells, including cancer cells, as well as hair growth and other non-malignant processes. One treatment option used to trigger the immune system to recognize that cancer is an enemy are therapeutic vaccines—a potential revolution in... Read More
Report from ASCO 2011
At this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, numerous posters and presentations explored issues related to ovarian cancer. Read on for highlights of research on treatment, screening and genetics. We will host a webinar summarizing research from the ASCO meeting on Thursday, June 16, 2011 at 1:00 pm. Dr. Deborah Armstrong of The Johns Hopkins School of Medicine will be the featured speaker. Register here to attend the webinar. Treatment Five... Read More
